Multi-omics exploration of biomolecular corona in nanomedicine therapeutics and diagnostics

Nanomedicine (Lond). 2024 Apr 9. doi: 10.2217/nnm-2024-0104. Online ahead of print.

Authors

Amir Ata Saei¹, Morteza Mahmoudi²

Affiliations

¹ Center for Translational Microbiome Research, Department of Microbiology, Tumor & Cell Biology, Karolinska Institutet, Stockholm, 17165, Sweden.
² Department of Radiology & Precision Health Program, Michigan State University, East Lansing, MI 48824, USA.

PMID: 38593028
DOI: 10.2217/nnm-2024-0104

No abstract available

Keywords: commercialization; corona; diagnostics; multi-omics; nanoparticles; therapeutics.

Publication types

Editorial

Grants and funding

DK131417/DK/NIDDK NIH HHS/United States